Posts

Medical Device Strategy Consulting and Sales Effectiveness: Aligning Strategy with Commercial Execution

Image
MedTech companies operate in one of the most demanding commercial environments in healthcare: long sales cycles, hospital value-analysis committees, group purchasing organizations, and increasingly data-driven buyers who expect outcomes evidence, not just product specifications. Getting a device strategy right — which markets to enter, how to price against incumbent technologies, how to sequence a product portfolio — only pays off if the sales organization can execute it. That's where medical device strategy consulting and sales effectiveness consulting come in. Though often discussed together, they solve different problems: one shapes what a company should bring to market and where, the other improves how well a sales team sells it. This article explains what each discipline covers, how they connect, and what to look for in a consulting partner. What Medical Device Strategy Consulting Covers Medical device strategy consulting typically addresses portfolio and product-line decisio...

Healthcare Consulting vs. Management Consulting: Choosing the Right Partner

Hospitals, health systems, payers, and other healthcare organizations face some of the most complex operating environments of any industry, combining regulatory requirements, thin margins, workforce shortages, and shifting reimbursement models. Many turn to healthcare consulting for help navigating these pressures, but healthcare consulting does not exist in isolation. It sits within the broader field of management consulting, and understanding how the two relate can help healthcare leaders choose the right type of partner for a given challenge. This article explains what each term covers, how they connect, and what to consider when selecting a consulting partner. What Management Consulting Covers Management consulting is a broad discipline focused on helping organizations improve performance, often by translating strategic direction into operational execution. Generalist management consultants work across industries, bringing structured problem-solving methods, benchmarking, and chang...

Sales Compensation Strategy: How Data and Analytics Consulting Strengthens Plan Design

  Sales compensation is one of the biggest levers a company has for shaping seller behavior — and one of the easiest to get wrong. Plans built on outdated assumptions, incomplete data, or gut instinct often end up too generous, too complex, or misaligned with what the business actually needs reps to do. That’s where data and analytics consulting comes in: using benchmarking, predictive modeling, and performance analysis to inform how compensation plans are structured and adjusted over time. This article explains what sales compensation involves, where data and analytics consulting adds measurable value, and what to consider when bringing in outside analytical support. What Sales Compensation Includes Sales compensation refers to the combination of base salary, commission, bonuses, and other incentives that reward sales performance. A sales compensation plan typically defines quotas, commission rates or tiers, accelerators for exceeding targets, and the specific metrics — revenue, n...

Drug Discovery Consulting and Clinical Trial Consulting: What Sponsors Should Know Before Engaging an Advisor

  Drug discovery consulting and clinical trial consulting both help organizations make better decisions in a field where decisions are expensive and hard to reverse. Discovery-stage teams ask whether a target and candidate justify further investment. Clinical teams ask whether a trial design, site strategy, and data plan can answer the questions regulators and payers will care about. This article explains what each type of advisory typically covers, how they connect, and how to select and measure a partner. What Drug Discovery Consulting Typically Involves Drug discovery consulting supports the early path from biological hypothesis to development candidate. Common areas include: •       Target identification and validation: reviewing the evidence that a target is relevant to a disease and tractable. •       Assay and screening strategy: assessing whether experiments will produce reliable, decision-ready data. •       Hit-to-lead an...

The Future of Health: Why Pharma and Life Sciences Leaders Are Rethinking Their Commercial Strategy

  Healthcare is being rebuilt in real time. Patent cliffs are compressing revenue windows, patients are behaving more like consumers, and artificial intelligence is quietly becoming the interface between clinicians and clinical information. For pharmaceutical and life sciences executives, the question is no longer whether the industry will change — it's whether their organization is structured to keep pace with it. That question is exactly why healthcare consulting firms have moved from a peripheral resource to a core part of how leading companies plan their next five years. Why the Future of Health Is a Strategic Question, Not Just a Clinical One It's tempting to think of the future of health as a story about science — new modalities, faster trials, better diagnostics. That's part of it, but the bigger shift is commercial and operational. Manufacturers are being asked to prove value, not just efficacy, to a widening circle of payers, providers, and increasingly price-sens...